CTX
Highly Engaged Employees
Computer Equipment & Peripherals · Michigan, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
14701 Harrison, Romulus, Michigan, 48174...Phone Number
(800) 447-5173Website
www.ctxintl.comRevenue
$19 MillionIndustry
About CTX
CTX Org Chart
Is CTX your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if CTX had a recent Job posting/layoffs
Earning: See what the market has to say on CTX recently announced quarterly report
CTX, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if CTX is spiking on competitors!
Website visits: Recent activity has been detected on your website
Product Launch: Get notified when CTX launches new products
Congratulate Masked Content for being promoted to Masked Content at CTX
Funding: Get notified immidiatlly once CTX has new funding data
Check if CTX has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Find VP level buyers at CTX
Find 2 more new buyers
Compare Similar Companies to CTX
Compare insights from companies similar to CTX, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
CTX is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
CTX is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about CTX.
CTX Tech Stack
A closer look at the technologies used by CTX
CTX News & Media
FDA Accepts Cingulate’s New Drug Application for CTx-1301 in Attention-Deficit/Hyperactivity Disorder (ADHD) and sets a May 31, 2026 PDUFA Date
KANSAS CITY, Kan., Oct. 14, 2025 (GLOBE NEWSWIRE) -- Cingulate Inc. (NASDAQ: CING) a biopharmaceutical company developing and advancing a pipeline of next-generation pharmaceutical products utilizing its proprietary Precision Timed Release™ (PTR™) drug-delivery platform, today announced that the U.S. Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for CTx-1301 (dexmethylphenidate), the company’s lead candidate for the treatment of Attention-Deficit/HyperCingulate Secures Exclusive Manufacturing Partnership with Bend Bio Sciences to Support Future Commercialization of Next Generation ADHD Treatment
Strategic Commercial Supply Agreement Positions Lead Asset CTx-1301 for Launch Pending FDA Approval Strategic Commercial Supply Agreement Positions Lead Asset CTx-1301 for Launch Pending FDA ApprovalCarbon Trade Exchange (CTX) embraces Crypto Carbon
GOLD COAST, QUEENSLAND, AUSTRALIA, August 11, 2025 /EINPresswire.com/ -- The recent announcement of U.S. regulations for stablecoins and cryptocurrencies has opened the door for a truly secure Crypto Carbon program. Global Environmental Markets (GEM), …
Top Computer Equipment & Peripherals Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding CTX
CTX Technology specializes in high-performance LCD displays and solutions, including the F973 19 LCD display featuring advanced Digital True View technology. Their product range includes touch screen monitors, open frame kits, and industrial PC solutions tailored for various industrial applications. The company aims to provide customizable viewing... Read More